CVS Health Corporation (CVS) is owned by a number of high-value investors. Its largest direct holder is Larry J. Merlo Director, President and Chief Executive Officer with 388,784 shares. The second-largest direct holder is Jonathan C. Roberts Executive Vice President and Chief Operating Officer, with 208,189 shares of the company’s stock. In third place with 131,798 shares of CVS is David W. Dorman Chairman of the Board.
Now turning to institutional ownership of CVS Health Corporation (CVS), The Vanguard Group, Inc. is the top holder with 101.62 million shares. The next largest fund holder of this company’s stock is SSgA Funds Management, Inc. with 60.59 million shares. In the third-place spot with 58.83 million shares is BlackRock Fund Advisors.
This company’s stock price was $74.71 at the previous market close, with its latest volume reaching 6380524. Compare that to its average daily volume of 7.02M. Given the fact that this stock has 1.30B shares outstanding, its current market value is sitting at $97.27B. This publicly-traded stock’s 60-month Beta is 0.87. Its Price to Sales ratio is 0.40, its Price to Cash Flow ratio is 12.92, and its Price to Book ratio is 1.55.
CVS stock has achieved a 5-day range of $73.60 to $75.91, with a total performance of -0.31% during that period. Meanwhile, in the past month of trading, this stock has traded in the range of $67.13 to $77.03, generating a +11.11% change during the period. In the past three months, this stock’s price has changed by +23.10%, trading in the range of $60.14 to $77.03.
In the past 5 days, shares of CVS have made a new high 2 times. In the last month, it has made a new high 12 times, and in the past 3 months, it has made a new high 23 times.
Now let’s turn to this public company’s earnings. For the quarter ending 9/29/2019, the earnings per share (EPS) was reported at 1.84. This is a 0.07 difference compared to the consensus estimate of 1.77, amounting to an earnings surprise of 4.00%. In the previous quarter, which ended in 9/29/2019, the consensus estimate was 1.69, making for an earnings surprise of 11.80%. For the quarter ending 3/30/2019, EPS was reported at 1.62, generating a 8.00% earnings surprise.
The Net Income for the most recent full fiscal year, which ended in 12-2018, was $-596.0 million. This is compared to the prior year, where Net Income was $6.62 billion. Meanwhile, this company’s Operating Cash Flow was $8.87 billion for the year, compared to $8.01 billion in 2017. Capital Expenditures for the year were reportedly -$2.04 billion, compared to -$1.92 billion, and Free Cash flow was $6.83 billion compared to the prior year’s $6.09 billion.
CVS Health Corporation (CVS) stock currently has a Financial Strength score of 4/10. This is due to a combination of factors, including a Cash to Debt ratio of 0.08, an Equity to Asset ratio of 0.28, a Debt to Equity ratio of 1.43 and a Debt to EBITDA of 6.46. The Interest Coverage of this stock is 4.03, its Piotroski F-Score is 6, its Altman Z-Score is 1.89.
This publicly-traded company’s Profitability and Growth score is 8/10, thanks to a combination of things: an Operating Margin of 5, a Net Margin of 1.83, a ROE of 8.02, and a ROC of 41.22.
Shifting focus now to Valuation and Return for CVS, this company’s Price to Median PS Value is 0.76. Price to Peter Lynch Fair Value for CVS is now 0.00. Meanwhile, its Forward Rate of Return (Yactman) is 8.31.
Certain ratios provide helpful insights into how a stock is performing. The Quick Ratio for CVS is sitting at 0.61, while its Current Ratio is 0.92. This stock’s PB Ratio is 1.54, its PS Ratio is 0.38, its Forward PE Ratio is 10.57, and its PE Ratio without NRI is 22.1. Similarly, its Shiller PE Ratio is 19.32, its Price to Owner Earnings is 12.81, its Price to Free Cash Flow is 9.24 and its Price to Operating Cash Flow is 7.44.